Timothy J. Seabrook

2.4k citations

31 papers · 1.7k indexed · 1 hit paper · h-index 19

Co-authors: Cynthia A. Lemere Marcel Maier Liying Jiang Ying Peng Michael C. Carroll E. T. C. Spooner Ksenija Gorni Marta Iglesias
Topics: Alzheimer's disease research and treatments (13 papers)Neuroinflammation and Neurodegeneration Mechanisms (10 papers)Neurogenetic and Muscular Disorders Research (9 papers)
Cited by: Neurology Biological Psychiatry Physiology
Journals: New England Journal of Medicine Journal of Neuroscience Neurology
Partner nations: United States Switzerland United Kingdom

In The Last Decade

Timothy J. Seabrook

30 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Risdiplam in Type 1 Spinal Muscular Atrophy

2021 260 citations Giovanni Baranello, Basil T. Darras et al. profile →

Peers

Countries citing papers authored by Timothy J. Seabrook

Since Specialization

Citations

This map shows the geographic impact of Timothy J. Seabrook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy J. Seabrook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy J. Seabrook more than expected).

Fields of papers citing papers by Timothy J. Seabrook

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy J. Seabrook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy J. Seabrook. The network helps show where Timothy J. Seabrook may publish in the future.

Co-authorship network of co-authors of Timothy J. Seabrook

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy J. Seabrook. A scholar is included among the top collaborators of Timothy J. Seabrook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy J. Seabrook. Timothy J. Seabrook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Validity and Reliability of the 32-Item Motor Function Measure in 2- to 5-Year-Olds with Neuromuscular Disorders and 2- to 25-Year-Olds with Spinal Muscular Atrophy 2020 ·Neurology and Therapy ·Dylan Trundell,(unknown),Ksenija Gorni,Timothy J. Seabrook,Carole Vuillerot,(unknown)	15
2	FIREFISH Part 1: 1-year event-free survival and swallowing ability in infants with Type 1 SMA 2019 ·Timothy J. Seabrook	1
3	FIREFISH Part 1: 1-Year Results on Motor Function in Babies with Type 1 SMA (S25.003) 2019 ·Neurology ·Giovanni Baranello,Laurent Servais,John Day,Nicolas Deconinck,Eugenio Mercuri,Andrea Klein,Basil T. Darras,Riccardo Masson,Heidemarie Kletzl,Yumi Cleary,Muna El-Khairi,Timothy J. Seabrook,Christian Czech,Marianne Gerber,(unknown),(unknown),Ksenija Gorni,Omar Khwaja	8
4	A series of case reports from JEWELFISH, an open-label study to investigate the safety, tolerability, and pharmacokinetics/ pharmacodynamics of RG7916 in adult and pediatric patients with spinal muscular atrophy who previously participated in a study with another SMN2-targeting therapy 2017 ·Neuromuscular Disorders ·Claudia A. Chiriboga,Eugenio Mercuri,David F. Fischer,Anne Marquet,Dominik Kraus,(unknown),(unknown),G. Armstrong,Heidemarie Kletzl,Christian Czech,Timothy J. Seabrook,(unknown),Lutz Mueller,Ksenija Gorni,Omar Khwaja	0
5	A Potent and Selective S1P1 Antagonist with Efficacy in Experimental Autoimmune Encephalomyelitis 2012 ·Chemistry & Biology ·Jean Quancard,Birgit Bollbuck,Philipp Janser,Daniela Angst,Frédéric Berst,(unknown),Markus Streiff,Christian Beerli,Volker Brinkmann,Danilo Guerini,Paul A. Smith,Timothy J. Seabrook,Martin Traebert,Klaus Seuwen,René Hersperger,Christian Bruns,Frédéric Bassilana,Marc Bigaud	100
6	The effect of FTY720 in the Theiler's virus model of multiple sclerosis 2011 ·Journal of the Neurological Sciences ·Libin Li,(unknown),Timothy J. Seabrook,(unknown),(unknown),Andrew R. Pachner	12
7	Angiogenesis is present in experimental autoimmune encephalomyelitis and pro-angiogenic factors are increased in multiple sclerosis lesions 2010 ·Journal of Neuroinflammation ·Timothy J. Seabrook,Amanda Littlewood-Evans,Volker Brinkmann,Bernadette Pöllinger,Christian Schnell,Peter Hiestand	67
8	Complement C3 Deficiency Leads to Accelerated Amyloid Plaque Deposition and Neurodegeneration and Modulation of the Microglia/Macrophage Phenotype in Amyloid Precursor Protein Transgenic Mice 2008 ·Journal of Neuroscience ·Marcel Maier,Ying Peng,Liying Jiang,Timothy J. Seabrook,Michael C. Carroll,Cynthia A. Lemere	267
9	Novel Aβ Immunogens: Is Shorter Better? 2007 ·Current Alzheimer Research ·Cynthia A. Lemere,Marcel Maier,Ying Peng,Liying Jiang,Timothy J. Seabrook	23
10	Amyloid-Beta Immunotherapy for the Prevention and Treatment of Alzheimer Disease: Lessons from Mice, Monkeys, and Humans 2006 ·Rejuvenation Research ·Cynthia A. Lemere,Marcel Maier,Liying Jiang,Ying Peng,Timothy J. Seabrook	55
11	Boosting with intranasal dendrimeric Aβ1–15 but not Aβ1–15 peptide leads to an effective immune response following a single injection of Aβ1–40/42 in APP-tg mice 2006 ·Journal of Neuroinflammation ·Timothy J. Seabrook,Liying Jiang,(unknown),Cynthia A. Lemere	21
12	Minocycline affects microglia activation, Aβ deposition, and behavior in APP‐tg mice 2006 ·Glia ·Timothy J. Seabrook,Liying Jiang,Marcel Maier,Cynthia A. Lemere	181
13	Dendrimeric Aβ1–15 is an effective immunogen in wildtype and APP-tg mice 2006 ·Neurobiology of Aging ·Timothy J. Seabrook,(unknown),Liying Jiang,(unknown),E. T. C. Spooner,Marcel Maier,Gal Bitan,Cynthia A. Lemere	48
14	Short Amyloid-β (Aβ) Immunogens Reduce Cerebral Aβ Load and Learning Deficits in an Alzheimer's Disease Mouse Model in the Absence of an Aβ-Specific Cellular Immune Response 2006 ·Journal of Neuroscience ·Marcel Maier,Timothy J. Seabrook,Noel D. Lazo,Liying Jiang,Pritam Das,Christopher Janus,Cynthia A. Lemere	114
15	Developing Novel Immunogens for an Effective, Safe Alzheimer’s Disease Vaccine 2005 ·Neurodegenerative Diseases ·Marcel Maier,Timothy J. Seabrook,Cynthia A. Lemere	16
16	Modulation of the humoral and cellular immune response in Aβ immunotherapy by the adjuvants monophosphoryl lipid A (MPL), cholera toxin B subunit (CTB) and E. coli enterotoxin LT(R192G) 2005 ·Vaccine ·Marcel Maier,Timothy J. Seabrook,Cynthia A. Lemere	36
17	Alzheimer's Disease Aβ Vaccine Reduces Central Nervous System Aβ Levels in a Non-Human Primate, the Caribbean Vervet 2004 ·American Journal Of Pathology ·Cynthia A. Lemere,Amy Beierschmitt,Marta Iglesias,E. T. C. Spooner,(unknown),(unknown),Jessica B. Zheng,Timothy J. Seabrook,(unknown),Diana Li,Dennis J. Selkoe,Roberta M. Palmour,Frank R. Ervin	186
18	Species-specific immune response to immunization with human versus rodent Aβ peptide 2004 ·Neurobiology of Aging ·Timothy J. Seabrook,(unknown),Marta Iglesias,E. T. C. Spooner,Dominic M. Walsh,Cynthia A. Lemere	21
19	Epinephrine causes a reduction in lymph node cell output in sheep 2001 ·Canadian Journal of Physiology and Pharmacology ·Timothy J. Seabrook,Bill Ristevski,Shawn G. Rhind,Pang N. Shek,J. Zámečník,Roy J. Shephard,John B. Hay	2
20	The use of the lipophilic fluorochrome CM-DiI for tracking the migration of lymphocytes 1996 ·Journal of Immunological Methods ·(unknown),Timothy J. Seabrook,Miles G. Johnston,John B. Hay	48

About Timothy J. Seabrook

Timothy J. Seabrook is a scholar working on Neurology, Genetics and Physiology, having authored 31 papers that have together received 1.7k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (13 papers), Neuroinflammation and Neurodegeneration Mechanisms (10 papers) and Neurogenetic and Muscular Disorders Research (9 papers). The work is most often cited by research in Neurology (635 citations), Biological Psychiatry (127 citations) and Physiology (751 citations). Timothy J. Seabrook has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Cynthia A. Lemere, Marcel Maier, Liying Jiang, Ying Peng, Michael C. Carroll, E. T. C. Spooner, Ksenija Gorni, Marta Iglesias, Nicolas Deconinck and Giovanni Baranello. Their work appears in journals such as New England Journal of Medicine, Journal of Neuroscience and Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact